|
|
Volumn 6, Issue 12, 2009, Pages 636-638
|
|
Health policy: The UK 'postcode lottery' in renal cell carcinoma
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYTOTOXIC AGENT;
ERLOTINIB;
IMATINIB;
SORAFENIB;
SUNITINIB;
TRASTUZUMAB;
ADVANCED CANCER;
BREAST CANCER;
CANCER IMMUNOTHERAPY;
CANCER SURVIVAL;
CLINICAL TRIAL;
COST EFFECTIVENESS ANALYSIS;
DRUG COST;
DRUG EFFICACY;
DRUG SAFETY;
GASTROINTESTINAL STROMAL TUMOR;
GEOGRAPHIC DISTRIBUTION;
HEALTH CARE ACCESS;
HEALTH CARE AVAILABILITY;
HEALTH CARE SYSTEM;
HUMAN;
KIDNEY CARCINOMA;
LUNG NON SMALL CELL CANCER;
PRIORITY JOURNAL;
PROGNOSIS;
PUBLIC HEALTH SERVICE;
QUALITY ADJUSTED LIFE YEAR;
RESOURCE ALLOCATION;
SHORT SURVEY;
UNITED KINGDOM;
ANTINEOPLASTIC AGENTS;
BENZENESULFONATES;
CARCINOMA, RENAL CELL;
GREAT BRITAIN;
HEALTH CARE RATIONING;
HUMANS;
INDOLES;
KIDNEY NEOPLASMS;
PYRIDINES;
PYRROLES;
REGIONAL HEALTH PLANNING;
SURVIVAL RATE;
|
|
EID: 75149180653
PISSN: 17594812
EISSN: 17594820
Source Type: Journal
DOI: 10.1038/nrurol.2009.228 Document Type: Short Survey |
|
Times cited : (3)
|
|
References (4)
|
